130 related articles for article (PubMed ID: 37917979)
1. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression.
Yang Z; Wan J; Ma L; Li Z; Yang R; Yang H; Li J; Zhou F; Ming L
J Clin Lab Anal; 2023 Jan; 37(1):e24801. PubMed ID: 36510377
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA CCAT2 Promotes the Development of Esophageal Squamous Cell Carcinoma by Inhibiting miR-200b to Upregulate the IGF2BP2/TK1 Axis.
Wu X; Fan Y; Liu Y; Shen B; Lu H; Ma H
Front Oncol; 2021; 11():680642. PubMed ID: 34386421
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis.
Wang C; Zhou M; Zhu P; Ju C; Sheng J; Du D; Wan J; Yin H; Xing Y; Li H; He J; He F
J Exp Clin Cancer Res; 2022 Dec; 41(1):347. PubMed ID: 36522683
[TBL] [Abstract][Full Text] [Related]
6. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
8. The m6A reader IGF2BP2 promotes esophageal cell carcinoma progression by enhancing EIF4A1 translation.
Li Y; Xiao Z; Wang Y; Zhang D; Chen Z
Cancer Cell Int; 2024 May; 24(1):162. PubMed ID: 38724996
[TBL] [Abstract][Full Text] [Related]
9. A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma.
Huang T; You Q; Huang D; Zhang Y; He Z; Shen X; Li F; Shen Q; Onyebuchi IC; Wu C; Liu F; Zhu S
Cell Commun Signal; 2024 Jan; 22(1):60. PubMed ID: 38254118
[TBL] [Abstract][Full Text] [Related]
10. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma.
Wang W; Ding Y; Zhao Y; Li X
Cancer Gene Ther; 2024 Feb; 31(2):285-299. PubMed ID: 38102465
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification.
Wu T; Liao L; Wu T; Chen S; Yi Q; Xu M
Cell Cycle; 2023 Oct; 22(20):2245-2263. PubMed ID: 37985379
[TBL] [Abstract][Full Text] [Related]
12. PolyC-RNA-binding protein 1 (PCBP1) enhances tropomyosin 3 (TPM3) mRNA stability to promote the progression of esophageal squamous cell carcinoma.
Peng K; Chen X; Lin A; Tong Z; Lin W
Bioengineered; 2022 Apr; 13(4):8581-8592. PubMed ID: 35287546
[TBL] [Abstract][Full Text] [Related]
13. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
14. linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA.
Huang GW; Chen QQ; Ma CC; Xie LH; Gu J
Int J Biochem Cell Biol; 2021 Jul; 136():106015. PubMed ID: 34022433
[TBL] [Abstract][Full Text] [Related]
15. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
16. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader.
Hu X; Peng WX; Zhou H; Jiang J; Zhou X; Huang D; Mo YY; Yang L
Cell Death Differ; 2020 Jun; 27(6):1782-1794. PubMed ID: 31804607
[TBL] [Abstract][Full Text] [Related]
19. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-2 mRNA-binding protein 3 promotes cell migration, invasion, and epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E-box-binding homeobox 1 mRNA.
Feng Y; Lin Y; Jiang Z; Wu L; Zhang Y; Wu H; Yuan X
Mol Carcinog; 2023 Apr; 62(4):503-516. PubMed ID: 36688673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
